Abstract
The main causative factor for the chronic liver disease is infection with hepatitis C virus (HCV). Around the world, it has been estimated that almost 180 million people are carriers of HCV. Infection with HCV leads to hepatocellular carcinoma (HCC) that is a frequent cause of mortality in HCV-infected patient. Among the most common cancers, it is ranked fifth worldwide. The annually death rate of HCC patients being caused by HCV is approximately 1 million. Epidemiological studies have demonstrated that prolong infection with HCV is the main threat for the development of HCC. Keeping the knowledge about the causes of cirrhosis and development of HCC in HCV patients is consequently very important for improving treatment choices and health-care delivery. Effective precautionary measures that can prevent the progression of HCC have now been well illustrated. The perfect natural explanation of HCC pathogenesis is so diverse that treatment strategies are highly difficult. Therefore, in the case of nonmalignant hepatic disease follow-up of the patients and treatment options must take into account to prevent the progression to carcinoma. In this review, we have strived to describe natural disease course of HCV infection and the ways through which it progresses to malignant hepatic disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Medicine, Radiology, Pathology and Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
